Fuan Pharmaceutical (300194.SZ) released its half-year financial results with a net profit attributable to the parent company of 1.13 billion yuan, representing a decrease of 47.74%.

Wisdom Financial APP News, Fuan Pharmaceutical (300194.SZ) released its semi-annual report for 2025, with the company's operating income at 0.921 billion yuan, a year-on-year decrease of 35.76%. The net profit attributable to the shareholders of the listed company was 0.113 billion yuan, a year-on-year decrease of 47.74%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 1.04 billion yuan, a year-on-year decrease of 48.84%. The basic earnings per share was 0.1 yuan.